The FDA has extended certain Drug Supply Chain Security Act (DSCSA) exemptions for small business dispensers through November 27, 2027. For qualifying pharmacies, the additional year provides more time to prepare for enhanced drug distribution security requirements, including interoperable electronic exchange and package-level product information.
For specialty pharmacies, the extension also creates an opportunity to review how product tracing, receiving, inventory, verification, quarantine, and returns are managed today, and how those processes will operate as electronic requirements continue to evolve.
Confirm Whether Your Pharmacy Qualifies
FDA defines a small business dispenser for this exemption as a dispenser whose owning corporate entity has a total of 25 or fewer full-time employees licensed as pharmacists or qualified as pharmacy technicians as of November 27, 2026.
The exemption is specific to certain DSCSA requirements. FDA states that qualifying small dispensers do not need to submit a request or notification to the agency to use the exemption.
Pharmacies should still maintain documentation supporting their eligibility, including the applicable employee count and qualification records.
What the Extension Covers
The extension provides qualifying small business dispensers additional time on specific enhanced drug distribution security requirements.
These include requirements related to secure, interoperable electronic exchange of transaction information and transaction statements, as well as package-level product identifiers. FDA also extended certain product identifier verification requirements related to suspect or illegitimate products.
The additional year gives pharmacies time to evaluate their systems, trading-partner processes, integrations, and data structures before the applicable requirements take effect.
The Broader DSCSA Responsibilities Continue
The extension does not remove the broader product tracing and verification responsibilities that apply to dispensers.
Pharmacies still need processes for working with authorized trading partners, maintaining product tracing documentation, and investigating suspect or illegitimate products. FDA states that pharmacies must retain product tracing documentation for six years and have processes to quarantine and investigate suspect product.
For specialty pharmacies handling high-value therapies, these responsibilities connect directly to inventory management.
That makes DSCSA an ERP consideration as well as a compliance consideration.
Where DSCSA Connects With NetSuite
The operational requirements of DSCSA map closely to information that specialty pharmacies already manage within their ERP.
Consider the receiving process.
A shipment arrives with product, lot information, expiration information, and transaction documentation. The receiving workflow needs to connect those records to the inventory entering the system.
In NetSuite, this can include structured lot and expiration capture, inventory locations or bins, receiving workflows, and reporting designed around exceptions.
The goal is to maintain a clear connection between the physical product and the information associated with it.
Lot and Expiration Data
Lot and expiration information provides an important foundation for pharmaceutical inventory traceability. For specialty pharmacies, this information can support receiving, inventory management, dispensing workflows, recalls, and product investigations.
Quarantine and Inventory Status
Product requiring investigation needs to remain separated from available inventory while the appropriate review takes place. NetSuite can support this through inventory statuses, locations, bins, workflows, and reporting that distinguish quarantined inventory from product available for dispensing. This can also give finance and operations teams visibility into inventory that remains on hand but is not currently available for use.
Transaction Information
Transaction information needs to remain connected to the associated product and transaction records. Structured processes for capturing and reviewing this information can help pharmacy teams identify exceptions and maintain a consistent record of product movement through the supply chain.
Returns
Returns create another important control point. Before returned product is returned to available inventory, pharmacies need an appropriate verification and disposition process. Connecting returns workflows with lot-level inventory records can help maintain traceability while keeping inventory status aligned with the product's actual disposition.
DSCSA Is Also an Inventory Visibility Opportunity
For specialty pharmacies, DSCSA processes can have operational and financial implications.
Consider a high-cost product placed into quarantine while associated information is reviewed.
The inventory still has financial value, but it may not be available for dispensing.
That makes it useful for finance and operations teams to understand not only total inventory, but also the quantity and value of inventory held in different statuses.
A well-configured NetSuite environment can bring these operational and financial perspectives together.
Finance can see inventory value. Operations can see product status. Compliance teams can review relevant transaction and traceability information.
Use the Additional Year to Prepare
Rather than treating November 2027 as a single deadline, specialty pharmacies can use the additional time to work through the process in stages.
Q4 2026: Establish your current position - Confirm whether the organization qualifies for the exemption and document the relevant employee count. Map current trading partners and how transaction information is received.
Q1 2027: Review data and workflows - Identify where product, lot, expiration, and transaction information enters the business. Define the information that needs to be captured and where it should reside.
Q2 2027: Test the process - Pilot electronic receipt and verification processes with selected trading partners. Track exceptions and the information required to resolve them.
Q3 2027: Expand the workflow - Extend the process across additional suppliers and trading partners. Refine integrations, exception handling, inventory statuses, and reporting.
Q4 2027: Validate readiness - Confirm that the process, systems, data, and trading-partner connections are operating as intended before the applicable requirements take effect.
Build DSCSA Into the ERP Strategy
The DSCSA extension gives qualifying small dispensers additional time, but it also creates an opportunity to connect compliance requirements with the systems already supporting the business.
For specialty pharmacies, that means looking across the entire product lifecycle: receiving, lot and expiration capture, inventory status, verification, quarantine, returns, and documentation.
NetSuite can provide the ERP foundation for connecting these processes. The value comes from configuring the workflows and data structure around the pharmacy's actual operating model.
As November 2027 approaches, the objective should be more than preparing for a regulatory milestone. It should be having an inventory and traceability environment where finance, operations, and compliance teams can work from consistent information.